MedPath

Qingdao Central Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab

Phase 2
Recruiting
Conditions
Pulmonary Fibrosis
Interventions
First Posted Date
2013-08-07
Last Posted Date
2023-03-29
Lead Sponsor
Qingdao Central Hospital
Target Recruit Count
30
Registration Number
NCT01917877
Locations
🇨🇳

Qingdao Central Hospital, Qingdao, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath